Extract FDA-approved BRANDED INNOVATIVE treatments for {{ disease }}.

=== CRITICAL: INDICATION-SPECIFIC FDA APPROVALS ONLY ===
Only count drugs with FDA approval for THIS EXACT INDICATION: "{{ disease }}"

IMPORTANT INDICATION DISTINCTIONS (different FDA labels):
- "Systemic Lupus Erythematosus (SLE)" ≠ "Lupus Nephritis" (different indications!)
  * SLE approved: Benlysta, Saphnelo
  * Lupus Nephritis approved: Lupkynis, Benlysta
- "Rheumatoid Arthritis" ≠ "Juvenile Idiopathic Arthritis"
- "Atopic Dermatitis" (adult) may have different approvals than pediatric
- "Crohn's Disease" ≠ "Ulcerative Colitis"

If analyzing "{{ disease }}", only count drugs FDA-approved for EXACTLY "{{ disease }}".
Do NOT count drugs approved for related but different indications.

=== BRANDED INNOVATIVE DRUGS ONLY ===
INCLUDE (is_branded_innovative=true):
- Biologics: monoclonal antibodies, fusion proteins, recombinant proteins
  Examples: Ilaris, Kineret, Actemra, Humira, Enbrel, Cosentyx, Stelara, Dupixent, Ocrevus
- Novel small molecules with brand names: JAK inhibitors, kinase inhibitors, targeted therapies
  Examples: Olumiant (baricitinib), Xeljanz (tofacitinib), Rinvoq (upadacitinib), Jakafi
- Specialty drugs: IVIG products, enzyme replacement therapies
  Examples: Octagam 10%, Gamunex-C, Cerezyme, Fabrazyme
- Gene/cell therapies: Zolgensma, Luxturna, Yescarta

EXCLUDE (is_branded_innovative=false):
- Generic drugs even with brand names: corticosteroids (prednisone, Medrol), methotrexate, azathioprine, cyclosporine
- Supportive care: NSAIDs, pain medications, antihistamines
- OTC medications: eye drops, topical steroids
- Branded generics: Cyclogyl (cyclopentolate), generic-equivalent products

Search Results:
{{ search_results | to_json }}

Return ONLY valid JSON:
{
    "top_treatments": [
        {
            "drug_name": "Brand Name (generic)",
            "drug_class": "class (e.g., IL-1 inhibitor, JAK inhibitor)",
            "is_branded_innovative": true/false,
            "fda_approved": true/false,
            "fda_approved_indication": "EXACT indication name from FDA label or null",
            "line_of_therapy": "1L/2L/3L or null",
            "efficacy_range": "60-70%",
            "annual_cost_usd": integer or null,
            "notes": "FDA approval details including specific indication"
        }
    ],
    "approved_drug_names": ["Brand1 (generic1)", "Brand2 (generic2)"],
    "num_approved_drugs": integer (count of drugs FDA-approved for EXACTLY "{{ disease }}"),
    "avg_annual_cost_usd": integer (average of branded innovative drugs only),
    "treatment_paradigm": "1-2 sentence description of treatment approach including line of therapy",
    "unmet_need": true/false,
    "unmet_need_description": "description or null",
    "competitive_landscape": "2-sentence summary",
    "soc_source": "source name and URL"
}

VALIDATION RULES:
1. fda_approved=true ONLY if FDA approved for EXACTLY "{{ disease }}" (not related conditions)
2. approved_drug_names MUST only contain drugs where is_branded_innovative=true AND fda_approved=true for THIS indication
3. num_approved_drugs MUST exactly equal length of approved_drug_names list
4. Generic drugs (corticosteroids, methotrexate, etc.) should NEVER appear in approved_drug_names
5. If drug is approved for related but different indication (e.g., Lupus Nephritis vs SLE), set fda_approved=false

{% include 'case_series/_partials/json_rules.j2' %}

